MP61-08 TOWARDS PERSONALIZED CARE OF CT1A PAPILLARY RCC DIAGNOSED ON BIOPSY
Johan Björklund(Karolinska University Hospital), Antonio Finelli(University Health Network), John R. Kachura, Robert J. Hamilton(Engineers Without Borders Canada), Michael Jewett, Alexandre R. Zlotta(University of Toronto), Douglas C. Cheung(University Health Network)
Cited by 0
Related Papers
Daclizumab phase II trial in relapsing and remitting multiple sclerosis
|Neurology|2007|161
The <i>FGFR3</i> Mutation is Related to Favorable pT1 Bladder Cancer
|The Journal of Urology|2011|102
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
|European Urology|2020|89
Prognostic value of molecular markers, sub‐stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer
|British Journal of Urology|2012|64
Dispatch of Firefighters and Police Officers in Out‐of‐Hospital Cardiac Arrest: A Nationwide Prospective Cohort Trial Using Propensity Score Analysis
|Journal of the American Heart Association|2017|62